Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Summary Safety Review - Topical Antiseptic Non-Prescription Chlorhexidine Products - Assessing the Potential Risk of Serious Allergic Reactions (hypersensitivity reactions)
- Summary Safety Review - Tramadol-containing Products - Assessing the Potential Risk of Serious Breathing Problems (Respiratory Depression) in Children and Adolescents
- Summary Safety Review - Trifecta Heart Valve - Assessing the Potential Risk of Early Wear
- Summary Safety Review - ULORIC (febuxostat) - Assessing a Possible Risk of Drug Reaction/Rash with Eosinophilia and Systemic Symptoms (DRESS)
- Summary Safety Review - Viscous Lidocaine 2% - Assessing the Potential Risk of Severe Side Effects in Infants and Young Children
- Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
- Summary Safety Review - Phenylephrine and acetaminophen - Drug-drug interaction
- Summary Safety Review - Over-the-counter topical acne products containing either BENZOYL PEROXIDE or SALICYLIC ACID - Assessing the potential risk of serious allergic reactions (serious hypersensitivity reactions)
- Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient Blood Supply (ischemic colitis)
- Agenda May 22 mai 2024
- Niagara Falls 2024 Tree Giveaway
- Niagara Falls 2024 Tree Giveaway WGS 1984
- Parking Tickets 2018
- Kingston Urban and Rural Areas
- Summary Safety Review - Oral Retinoid Products - Assessing the Potential Risk of Impotence (erectile dysfunction)
- Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk of Retinal Detachment
- Summary Safety Review - Omnipod Insulin Management System - Assessing the potential risk of malfunctions with the device
- Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents
- Summary Safety Review - Loratadine - Abnormal heart rhythm (QT interval prolongation)
- Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
- Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin
- Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential Risk of Acute Kidney Injury (Acute renal failure/Interstitial nephritis)
- Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing the Potential Risk of Raynaud's Phenomenon
- Summary Safety Review - Intraocular lenses - Assessing the potential risk of developing small pockets of liquid in intraocular lenses (glistening)
- Summary Safety Review - Hydroxyzine (ATARAX and generics) - Assessing the Potential Risk of Abnormal Heart Rhythm
- Summary Safety Review - Hydrocodone-containing products - Assessing the Risk of Serious Breathing Problems (respiratory depression) in Children and Adolescents
- Summary Safety Review - Green tea extract-containing natural health products - Assessing the potential risk of liver injury (hepatotoxicity)
- Summary Safety Review - GARDASIL (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) - Assessing General Safety with a Focus on Autoimmune and Cardiovascular Diseases
- Summary Safety Review - Gadolinium based contrast agents - Assessing the risk of gadolinium build-up in the brain and potential brain and nervous system (neurological) side effects
- Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious Breathing Problems
- Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
- Summary Safety Review - Finasteride - Assessing the Potential Risk of Suicidal Thoughts and Behaviour (Suicidality)
- Summary Safety Review - Finasteride - Assessing the Potential Risk of Serious Muscle-Related Side Effects
- Summary Safety Review - EYLEA (aflibercept) - Assessing the Risk of Side Effects Outside the Eye (systemic side effects)
- 2024-05-06 Decisions décisions
- Revalidation of the Custody Rating Scale for Indigenous Men Offenders
- Validation of the Custody Rating Scale for Black Men Offenders
- Revalidation of the Custody Rating Scale for Non-Indigenous Women Offenders
- Revalidation of the Custody Rating Scale for Indigenous Women Offenders
- Prevalence rates of infectious diseases among offenders in federal custody
- Summary Safety Review - ABILIFY and ABILIFY MAINTENA (aripiprazole) - Evaluating the Risk of Certain Impulse Control Behaviours
- Summary Safety Review - Alpha Lipoic Acid - Assessing the Potential Risk of Low Blood Sugar (Hypoglycemic Episodes)
- Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)
- Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
- Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
- Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
- Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis)
- Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)
- Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)